-
2301
A Very Low–Carbohydrate Program in Adults With Metabolic Dysfunction–Associated Steatotic Liver Disease and Phospholipase Domain–Containing Protein 3 Risk Genotype: Pre-Post Interv...
Published 2025-01-01“…Across participants with a 4-month hepatic liver fat percent measurement, the percent change in liver fat was −33.17% (95% CI −86.48 to 20.14), and in only the participants who were adherent to the eating pattern, the percent change in liver fat was −53.12% (95% CI −71.25 to −34.99). …”
Get full text
Article -
2302
Case report: A study on the pathological diagnosis of oral fibrosarcoma in a giant panda
Published 2025-02-01“…Hematological tests revealed elevated levels of the tumor marker CA724, along with infectious disease, anemia, hepatic damage, and renal failure. Imaging studies identified a soft tissue mass in the right cheek area. …”
Get full text
Article -
2303
Image-Based Analysis of Tumor Localization After Intra-Arterial Delivery of Technetium-99m-Labeled SPIO Using SPECT/CT and MRI
Published 2017-01-01“…Intra-arterial delivery of SPIO with Lipiodol might be a good drug delivery system targeting the hepatic tumors, as confirmed by image-based analysis.…”
Get full text
Article -
2304
Dual role of pyroptosis in liver diseases: mechanisms, implications, and therapeutic perspectives
Published 2025-01-01“…Conversely, excessive pyroptosis intensifies inflammatory responses, exacerbates hepatocyte damage and promotes the activation and proliferation of hepatic stellate cells, accelerating liver fibrosis. …”
Get full text
Article -
2305
Forgettable in the care of liver cirrhosis: the unseen culprits of progression from bad to worse
Published 2024-03-01“…The lack of disease-specific nutritional guidance, the prevalent sedentary lifestyle among patients, and insufficient screening for hepatocellular carcinoma, oesophageal varices, sarcopaenia, minimal hepatic encephalopathy, and diabetes mellitus, along with fibrosis progression and cirrhosis decompensation, can add further complexities. …”
Get full text
Article -
2306
The Successful Use of Inhaled Nitric Oxide in the Management of Severe Hepatopulmonary Syndrome after Orthotopic Liver Transplantation
Published 2014-01-01“…Hepatopulmonary syndrome (HPS) is characterized by pulmonary vasodilation and subsequent hypoxemia in the setting of hepatic dysfunction. There is currently no pharmacologic intervention that has been shown to significantly affect outcomes and liver transplantation remains the mainstay of therapy. …”
Get full text
Article -
2307
Raoultella Planticola Bacteremia Following Consumption of Seafood
Published 2014-01-01“…Recent chemotherapy, proton pump inhibitor use and altered biliary flow secondary to hepatic metastases may have been contributing factors to the pathogenesis of disease.…”
Get full text
Article -
2308
Human Liver-Derived Stem Cells Improve Fibrosis and Inflammation Associated with Nonalcoholic Steatohepatitis
Published 2019-01-01“…In addition, HLSCs show a specific commitment to the hepatic phenotype. Injection of HLSCs into immunodeficient mice fed with a methionine-choline-deficient diet to induce nonalcoholic steatohepatitis ameliorates liver function and morphology. …”
Get full text
Article -
2309
Is There a Role for Probiotics in Liver Disease?
Published 2014-01-01“…There is mounting evidence that probiotics are effective in the treatment of covert and overt hepatic encephalopathy, as well as in the prevention of recurrence of encephalopathy. …”
Get full text
Article -
2310
Methods of risk prediction and monitoring of treatment response rate of bleedings from esophageal varices in patients with liver cirrhosis
Published 2012-04-01“…Gastroduodenoscopy and hepatic venous pressure gradient measurement remain to be the standard methods of screening diagnostics of patients with liver cirrhosis for estimation of VEV bleeding risk nowadays. …”
Get full text
Article -
2311
Chronic Disseminated Candidiasis Complicated by Immune Reconstitution Inflammatory Syndrome in Child with Acute Lymphoblastic Leukemia
Published 2016-01-01“…We report a case of probable hepatic candidiasis in 4-year-old boy with acute lymphoblastic leukemia. …”
Get full text
Article -
2312
FIRST RUSSIAN EXPERIENCE OF USING THE INTEGRATED SYSTEM OF LASER THERMOABLATION THERAPY IN THE TREATMENT OF METASTATIC LIVER CANCER
Published 2017-09-01“…In patients with a reduced functional reserve of the liver or a missing volume of the remaining liver parenchyma, these interventions become impossible because of the increased risk of postresectional acute hepatic insufficiency. One of the most modern and promising ways to overcome this obstacle is the use of minimally invasive methods of tumor destruction. …”
Get full text
Article -
2313
Systemic and Local CC Chemokines Production in a Murine Model of Listeria monocytogenes Infection
Published 2006-01-01“…Repeated intragastric inoculation of Listeria monocytogenes into BALB/c mice resulted in prolonged bacteraemia and severe hepatic infection. Bacteria could also be isolated from the brain tissue of all experimental mice. …”
Get full text
Article -
2314
Transdermal patches: Design and current approaches to painless drug delivery
Published 2019-06-01“…Use of transdermal patches can evade many issues associated with oral drug delivery, such as first-pass hepatic metabolism, enzymatic digestion attack, drug hydrolysis and degradation in acidic media, drug fluctuations, and gastrointestinal irritation. …”
Get full text
Article -
2315
Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease
Published 2010-01-01“…Upon stimulation by these TLR ligands, hepatic immune cells produce various mediators that are involved in host defense. …”
Get full text
Article -
2316
Atypical Presentation of Cat-Scratch Disease in an Immunocompetent Child with Serological and Pathological Evidence
Published 2014-01-01“…Herein we present a case of systemic CSD presenting with hepatic mass in an immunocompetent child. The differential diagnosis is made by serological and pathological evidence. …”
Get full text
Article -
2317
Inter-organ metabolic interaction networks in non-alcoholic fatty liver disease
Published 2025-01-01“…This disease is closely associated with metabolic disorders driven by overnutrition, with key pathological processes including lipid dysregulation, impaired lipid autophagy, mitochondrial dysfunction, endoplasmic reticulum (ER) stress, and local inflammation. While hepatic lipid metabolism in NAFLD is well-documented, further research into inter-organ communication mechanisms is crucial for a deeper understanding of NAFLD progression. …”
Get full text
Article -
2318
Advances and current concepts on Eph receptors and ephrins in upper digestive tract cancers
Published 2025-01-01“…The Eph/ephrin system has been described as a tumor suppressor in duodenal cancer, while in esophageal, gastric, hepatic, and pancreatic cancer, the system has been related to tumor progression. …”
Get full text
Article -
2319
Peritoneal dialysis in an end-stage renal disease patient with massive ascites and primary liver cancer
Published 2024-12-01“…We present a case of a 68-year-old male patient with ESRD who experienced various decompensated complications of liver cirrhosis, particularly massive ascites and hepatic space-occupying lesions. Peritoneal dialysis (PD) catheter insertion and continuous ambulatory peritoneal dialysis (CAPD) treatment were successfully performed. …”
Get full text
Article -
2320
Case Report of Probable DRESS Syndrome Associated with Ribociclib
Published 2023-01-01“…Here, we present the case of an 83-year-old patient who developed a probable DRESS syndrome induced by ribociclib, presenting with fever, eosinophilia, rash, and hepatic cytolysis. The RegiSCAR score was 4. The symptomatology evolved favorably with topical and systemic corticosteroids, without any sequel. …”
Get full text
Article